Table 1.
Developmental status of PET tracers for imaging neuroinflammation
| Biomarker | Tracer | Developmental status | references | |||
|---|---|---|---|---|---|---|
| Radiochemical | Pre-clinical | Clinical | ||||
| Rodent | Non-human primate | |||||
| TSPO | [11C]PK11195 | √ | √ | √ | √ | [103–106] |
| [11C]DAA1106 | √ | √ | √ | √ | [17, 107–109] | |
| [11C]DPA713 | √ | √ | √ | √ | [110–113] | |
| [18F]PBR06 | √ | √ | √ | √ | [114–116] | |
| [11C]PBR28 | √ | √ | √ | √ | [117–120] | |
| [18F]DPA714 | √ | √ | √ | √ | [111, 121, 122] | |
| [18F]GE180 | √ | √ | - | √ | [120, 123, 124] | |
| [11C]ER176 | √ | √ | √ | √ | [33, 125–127] | |
| [18F]BS224 | √ | √ | - | - | [35] | |
| Adenosine | [11C]TMSX | √ | √ | √ | √ | [128, 129] |
| [11C]SCH442416 | √ | √ | √ | √ | [130–132] | |
| [11C]MPDX | √ | √ | √ | √ | [133, 134] | |
| [18F]CPFPX | √ | √ | √ | √ | [133, 135–137] | |
| [11C]Preladenant | √ | √ | √ | √ | [138–140] | |
| [18F]MNI-444 | √ | - | √ | √ | [46, 141, 142] | |
| CB2 | [11C]Methoxy-Sch225336 | √ | - | - | - | [51] |
| [11C]NE40 | √ | √ | √ | √ | [53, 143] | |
| [11C]A-836339 | √ | √ | - | - | [54] | |
| [11C]GW405833 | √ | √ | - | - | [58] | |
| [18F]MA3 | √ | √ | √ | - | [59, 60] | |
| COX | [11C]KTP-Me | √ | √ | - | √ | [63, 144, 145] |
| [11C]PS13 | √ | - | √ | √ | [146, 147] | |
| [11C]MC1 | √ | - | √ | - | [65, 148] | |
| P2X7 | [11C]JNJ-54173717 | √ | √ | √ | √ | [68, 69] |
| [18F]JNJ-64413739 | √ | √ | √ | √ | [70, 71, 149] | |
| CSF-1 | [11C]AZ683 | √ | √ | √ | - | [73] |
| [11C]CPPC | √ | √ | √ | √ | [74, 150] | |
| I2BS | [11C]FTIMD | √ | √ | √ | - | [76, 77] |
| [11C]metrazoline | √ | - | - | - | [80] | |
| [11C]TEIMD | √ | - | - | - | [80] | |
| [11C]BU99008 | √ | √ | √ | √ | [151–154] | |
| [18F]FEBU | √ | √ | - | - | [79] | |
| MAO-B | [11C]L-deprenyl | √ | - | - | √ | [87, 155] |
| [11C]DED | √ | √ | - | √ | [88, 156, 157] | |
| [11C]SL25.1188 | √ | - | √ | √ | [89, 158, 159] | |
| [18F]DED | √ | √ | √ | √ | [93, 160] | |
| [18F]FSL25.1188 | √ | - | √ | - | [94] | |
| [18F]SMBT-1 | √ | - | - | √ | [95, 161] | |